Evidence map›Paper›PMID 38707210›Full record

ArticleMitochondrial DNA. Part B, Resources2024

The complete chloroplast genome sequence of leibnitzia anandria (linnaeus) turczaninow.

Binghua Ru, Ting Wang, Yongfeng Liu, Xiaochao Zhao, Ming Lei

Abstract read
In one paragraph

Article in Mitochondrial DNA. Part B, Resources, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The complete chloroplast genome ofMitochondrial DNA. Part B, Resources · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Binghua RuShanghai Origingene Biotechnology Company Limited, Shang Hai, China.
Ting WangShanghai Origingene Biotechnology Company Limited, Shang Hai, China.
Yongfeng LiuGeneMind Biosciences Company Limited, Shen Zhen, China.
Xiaochao ZhaoGeneMind Biosciences Company Limited, Shen Zhen, China.
Ming LeiShanghai Origingene Biotechnology Company Limited, Shang Hai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leibnitzia anandria is a perennial herbaceous plant with medicinal properties, and the entire plant can be used in traditional medicine. Leibnitzia anandria was once classified under the genus Gerbera Cass., but was reclassified under Leibnitzia Cass. recently. In this study, using the GeneLab M sequencing technology of the Genemind platform, we have sequenced, assembled, and analyzed the complete chloroplast genome of Leibnitzia anandria for the first time. The genome is 154168 bp in length, consisting of a large single-copy region(LSC, 80166 bp), a small single-copy region(SSC, 18202 bp), and a pair of inverted repeat sequences(IR, 27900 bp). We have predicted and annotated a total of 133 genes, including 88 protein-coding genes, 37 tRNA-coding genes, and 8 rRNA-coding genes. The results of the phylogenetic analysis indicate that Leibnitzia anandria and Leibnitzia nepalensis, as well as the closely related Gerbera plant, clustered into a separate clade, rather than grouping together with the other plants belonging to the tribe Mutisieae. This study provides new information for the phylogeny research of Leibnitzia anandria, contributing to a better understanding of its taxonomy and evolution.

Indexed as

Chloroplast genomicsGeneLab M sequencingmedicinal plantsphylogenetic analysis

Identifiers

PMID38707210
PMCPMC11067557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.